Login / Signup

The incidence of immune-related adverse events (irAEs) and their association with clinical outcomes in advanced renal cell carcinoma and urothelial carcinoma patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.

Yaowen ZhangJunru ChenHaoyang LiuJindong DaiJunjie ZhaoSha ZhuXingming ZhangJiayu LiangXu HuJinge ZhaoZhenhua LiuPengfei ShenGuangxi SunHao Zeng
Published in: Cancer treatment reviews (2024)
Our findings suggest that the occurrence of irAEs could be considered as a potential prognostic factor for predicting the efficacy of ICIs in patients with advanced RCC and UC.
Keyphrases
  • renal cell carcinoma
  • prognostic factors
  • risk assessment
  • risk factors
  • human health